Schedule 13D ownership disclosure

TRANSGENOMIC INC

Security class unavailable · CUSIP: 89365K206

Event date: 2016-10-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,061,047
Percent of class
35.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-128979
Form type
SC 13D
Filer
Precipio Diagnostics, LLC
CIK
CIK 1531859
Filed
Oct 21, 2016
Reporting period
Oct 12, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub